Barclays
CVET

Barclays’s Covetrus, Inc. Common Stock CVET Stock Holding History

Barclays’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-214,220
Closed -$4.47M – 5608
2022
Q3 		$4.47M Buy
214,220
+128,481
+150% +$2.67M ﹤0.01% 1228
2022
Q2 		$1.78M Sell
85,739
-49,108
-36% -$874K ﹤0.01% 1933
2022
Q1 		$2.26M Sell
134,847
-38,483
-22% -$673K ﹤0.01% 1773
2021
Q4 		$3.46M Buy
173,330
+65,214
+60% +$1.23M ﹤0.01% 1977
2021
Q3 		$1.96M Buy
108,116
+44,931
+71% +$1.03M ﹤0.01% 2376
2021
Q2 		$1.71M Sell
63,185
-85,040
-57% -$2.38M ﹤0.01% 2295
2021
Q1 		$4.44M Sell
148,225
-10,960
-7% -$374K ﹤0.01% 1617
2020
Q4 		$4.57M Sell
159,185
-13,299
-8% -$359K ﹤0.01% 1572
2020
Q3 		$4.21M Buy
172,484
+58,511
+51% +$1.26M ﹤0.01% 1513
2020
Q2 		$2.04M Sell
113,973
-88,569
-44% -$1.16M ﹤0.01% 2109
2020
Q1 		$1.65M Sell
202,542
-22,334
-10% -$255K ﹤0.01% 2468
2019
Q4 		$2.97M Buy
224,876
+179,782
+399% +$2.18M ﹤0.01% 2581
2019
Q3 		$535K Sell
45,094
-13,712
-23% -$254K ﹤0.01% 4196
2019
Q2 		$1.44M Buy
58,806
+25,881
+79% +$746K ﹤0.01% 3296
2019
Q1 		$1.05M Buy
+32,925
New +$1.17M ﹤0.01% 3348

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's CVET Position: Q4 2022 in Review

Barclays sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 214,220 shares — an estimated $4.47M sold.

Barclays first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $4.57M in Q4 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Barclays reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 214,220 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $4.47M.
  • Barclays first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Barclays's Covetrus, Inc. Common Stock position peaked at $4.57M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.